Tizanidine Tablet
Product Images NDC 82461-720

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 82461-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medcore Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure of Tizanidine hydrochloride, showing its molecular framework with distinct chlorine and heterocyclic nitrogen-containing rings.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A line graph showing plasma tizanidine concentration (ng/mL) over 24 hours after dosing. It compares 4 mg tizanidine tablets and capsules taken with and without food, illustrating changes in concentration over time post-dose.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph showing improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis measures improvement scores, with three labeled lines representing each treatment group's response up to 6 hours after dosing.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A chart depicting improvement in Ashworth Scores over time comparing tizanidine (mean dose 28.8 mg) and placebo. The x-axis shows three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis represents improvement scores, with tizanidine consistently showing greater improvement than placebo at each time point.*

FDA Label Image

2 mg Tablet Bottle Label (Tizanidine 5)

Tizanidine tablets, USP 2 mg oral tablets packaged by Medcore LLC, labeled with NDC 82461-720-60. The label states each tablet contains 2 mg of tizanidine, includes storage instructions, pharmacist information, and a warning that tablets are not interchangeable with capsules. The package contains 60 tablets. Contact and lot information are provided on the label.*

FDA Label Image

4 mg Tablet Bottle Label (Tizanidine 6)

Tizanidine 4 mg tablets label from Medcore LLC. The label shows the drug name, strength, and dosage form as tablets USP. It specifies the content per tablet as 4.576 mg tizanidine HCl equivalent to 4 mg tizanidine base. The package includes 60 tablets, is Rx only, and advises that tablets are not interchangeable with capsules. Storage instructions and pharmacist information for dispensing in child-resistant containers are also present. Contact and distributor details of Medcore LLC are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.